过去一年中添加的文章,按日期排序

SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment

V Suresh, MA Shamim, V Ghosh, T Dave, M Jayan… - 2024 - researchsquare.com
76 天前 - … a reduced risk of COVID-19-related mortality in patients taking antidiabetic medications.
… We performed an umbrella review of systematic reviews and meta-analyses on SGLT2i …

A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes

S Ashique, N Mishra, A Garg, S Garg, A Farid… - The American Journal of …, 2024 - Elsevier
119 天前 - … Various therapeutic approaches, including anti-diabetic drugsDiabetes increases
the morbidity and mortality risk for … systematic review, the combined prevalence of diabetes in …

… co-transporter-2 inhibitors against intensive care unit admission and mortality in the acute phase of the COVID-19 pandemic: a retrospective observational study in …

VM Monda, C Voci, F Strollo, A Passaro, S Greco… - Diabetes Therapy, 2023 - Springer
277 天前 - … effect of hypoglycemic drugs in patients with COVID-19 and … We selected subjects
with type 2 diabetes who were older … systematic review and meta-analysis showing reduced …